NCT02537938View on ClinicalTrials.gov

Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Alzheimer's Disease
Interventions
DRUG

NGP 555

Trial Locations (1)

90630

WCCT Global, Cypress

Sponsors

Collaborators (1)

WCCT Global
All Listed Sponsors
collaborator

WCCT Global

INDUSTRY

lead

NeuroGenetic Pharmaceuticals Inc

INDUSTRY

NCT02537938 - Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose) | Biotech Hunter | Biotech Hunter